| CRISPR | Clustered regularly interspaced short palindromic repeats |
| DNE | Dominant negative effect |
| GOF | Gain of function |
| LFS | Li–Fraumeni syndrome |
| LOF | Loss of function |
| WT | Wild-type |
| CRISPR | Clustered regularly interspaced short palindromic repeats |
| DNE | Dominant negative effect |
| GOF | Gain of function |
| LFS | Li–Fraumeni syndrome |
| LOF | Loss of function |
| WT | Wild-type |